{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T18:06:26Z","timestamp":1772388386846,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03056-3","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T10:01:23Z","timestamp":1717840883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Aspirin as a chemopreventive agent for cutaneous melanoma: a literature review"],"prefix":"10.1007","volume":"316","author":[{"given":"Anika","family":"Pulumati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanci A.","family":"Algarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Jaalouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Latta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyvan","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,8]]},"reference":[{"issue":"5 Suppl 1","key":"3056_CR1","first-page":"S17","volume":"65","author":"A Jemal","year":"2011","unstructured":"Jemal A, Saraiya M, Patel P et al (2011) Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992\u20132006. J Am Acad Dermatol 65(5 Suppl 1):S17\u201325.e1-3","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"3056_CR2","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1053\/j.seminoncol.2007.09.012","volume":"34","author":"JS Bordeaux","year":"2007","unstructured":"Bordeaux JS, Lu KQ, Cooper KD (2007) Melanoma: prevention and early detection. Semin Oncol 34(6):460\u2013466. https:\/\/doi.org\/10.1053\/j.seminoncol.2007.09.012","journal-title":"Semin Oncol"},{"issue":"4","key":"3056_CR3","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/CEJ.0b013e328339648c","volume":"19","author":"W Tian","year":"2010","unstructured":"Tian W, Zhao Y, Liu S, Li X (2010) Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer. Eur J Cancer Prev off J Eur Cancer Prev Organ ECP 19(4):288\u2013298. https:\/\/doi.org\/10.1097\/CEJ.0b013e328339648c","journal-title":"Eur J Cancer Prev off J Eur Cancer Prev Organ ECP"},{"issue":"9754","key":"3056_CR4","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","volume":"376","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Wilson M, Elwin CE et al (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet Lond Engl 376(9754):1741\u20131750. https:\/\/doi.org\/10.1016\/S0140-6736(10)61543-7","journal-title":"Lancet Lond Engl"},{"issue":"18","key":"3056_CR5","first-page":"6096","volume":"63","author":"RE Harris","year":"2003","unstructured":"Harris RE, Chlebowski RT, Jackson RD et al (2003) Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the women\u2019s Health Initiative. Cancer Res 63(18):6096\u20136101","journal-title":"Cancer Res"},{"issue":"9671","key":"3056_CR6","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(09)60243-9","volume":"373","author":"PC Elwood","year":"2009","unstructured":"Elwood PC, Gallagher AM, Duthie GG, Mur LAJ, Morgan G (2009) Aspirin, salicylates, and cancer. Lancet Lond Engl 373(9671):1301\u20131309. https:\/\/doi.org\/10.1016\/S0140-6736(09)60243-9","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"3056_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1200\/JCO.2005.09.112","volume":"23","author":"AJ Dannenberg","year":"2005","unstructured":"Dannenberg AJ, Lippman SM, Mann JR, Subbaramaiah K, DuBois RN (2005) Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol off J Am Soc Clin Oncol 23(2):254\u2013266. https:\/\/doi.org\/10.1200\/JCO.2005.09.112","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"issue":"1","key":"3056_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/CMR.0b013e32831d7f52","volume":"19","author":"MR Becker","year":"2009","unstructured":"Becker MR, Siegelin MD, Rompel R, Enk AH, Gaiser T (2009) COX-2 expression in malignant melanoma: a novel prognostic marker? Melanoma Res 19(1):8\u201316. https:\/\/doi.org\/10.1097\/CMR.0b013e32831d7f52","journal-title":"Melanoma Res"},{"issue":"1","key":"3056_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/01.cmr.0000194430.77643.a0","volume":"16","author":"L Ku\u017abicki","year":"2006","unstructured":"Ku\u017abicki L, Sarnecka A, Chwirot BW (2006) Expression of cyclooxygenase-2 in benign naevi and during human cutaneous melanoma progression. Melanoma Res 16(1):29\u201336. https:\/\/doi.org\/10.1097\/01.cmr.0000194430.77643.a0","journal-title":"Melanoma Res"},{"issue":"57","key":"3056_CR10","doi-asserted-by":"publisher","first-page":"9247","DOI":"10.1038\/sj.onc.1208169","volume":"23","author":"Y Takada","year":"2004","unstructured":"Takada Y, Bhardwaj A, Potdar P, Aggarwal BB (2004) Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene 23(57):9247\u20139258. https:\/\/doi.org\/10.1038\/sj.onc.1208169","journal-title":"Oncogene"},{"issue":"6","key":"3056_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/CMR.0b013e3283107df7","volume":"18","author":"NM Vad","year":"2008","unstructured":"Vad NM, Yount G, Moridani MY (2008) Biochemical mechanism of acetylsalicylic acid (aspirin) selective toxicity toward melanoma cell lines. Melanoma Res 18(6):386\u2013399. https:\/\/doi.org\/10.1097\/CMR.0b013e3283107df7","journal-title":"Melanoma Res"},{"issue":"6706","key":"3056_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/23948","volume":"396","author":"MJ Yin","year":"1998","unstructured":"Yin MJ, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396(6706):77\u201380. https:\/\/doi.org\/10.1038\/23948","journal-title":"Nature"},{"issue":"8","key":"3056_CR13","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1002\/cncr.27817","volume":"119","author":"CA Gamba","year":"2013","unstructured":"Gamba CA, Swetter SM, Stefanick ML et al (2013) Aspirin is associated with lower melanoma risk among postmenopausal caucasian women: the women\u2019s Health Initiative. Cancer 119(8):1562\u20131569. https:\/\/doi.org\/10.1002\/cncr.27817","journal-title":"Cancer"},{"issue":"7","key":"3056_CR14","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/jid.2011.58","volume":"131","author":"C Curiel-Lewandrowski","year":"2011","unstructured":"Curiel-Lewandrowski C, Nijsten T, Gomez ML, Hollestein LM, Atkins MB, Stern RS (2011) Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study. J Invest Dermatol 131(7):1460\u20131468. https:\/\/doi.org\/10.1038\/jid.2011.58","journal-title":"J Invest Dermatol"},{"issue":"11","key":"3056_CR15","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1038\/jid.2009.201","volume":"129","author":"A Joosse","year":"2009","unstructured":"Joosse A, Koomen ER, Casparie MK, Herings RMC, Guchelaar HJ, Nijsten T (2009) Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study. J Invest Dermatol 129(11):2620\u20132627. https:\/\/doi.org\/10.1038\/jid.2009.201","journal-title":"J Invest Dermatol"},{"key":"3056_CR16","doi-asserted-by":"publisher","first-page":"102173","DOI":"10.1016\/j.canep.2022.102173","volume":"79","author":"MK Yan","year":"2022","unstructured":"Yan MK, Orchard SG, Adler NR et al (2022) Association between hypertension and cutaneous melanoma, and the effect of aspirin: extended follow-up of a large randomised controlled trial. Cancer Epidemiol 79:102173. https:\/\/doi.org\/10.1016\/j.canep.2022.102173","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"3056_CR17","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jaad.2015.03.019","volume":"72","author":"S Famenini","year":"2015","unstructured":"Famenini S, Duan L, Young L (2015) Aspirin use and melanoma: a UCLA pilot study. J Am Acad Dermatol 72(6):1094\u20131095. https:\/\/doi.org\/10.1016\/j.jaad.2015.03.019","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3056_CR18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jaad.2017.12.076","volume":"78","author":"S Rachidi","year":"2018","unstructured":"Rachidi S, Wallace K, Li H, Lautenschlaeger T, Li Z (2018) Postdiagnosis aspirin use and overall survival in patients with melanoma. J Am Acad Dermatol 78(5):949\u2013956e1. https:\/\/doi.org\/10.1016\/j.jaad.2017.12.076","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"3056_CR19","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s10552-012-0019-6","volume":"23","author":"JM Jeter","year":"2012","unstructured":"Jeter JM, Han J, Martinez ME, Alberts DS, Qureshi AA, Feskanich D (2012) Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the nurses\u2019 Health Study. Cancer Causes Control CCC 23(9):1451\u20131461. https:\/\/doi.org\/10.1007\/s10552-012-0019-6","journal-title":"Cancer Causes Control CCC"},{"issue":"4","key":"3056_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.jaad.2018.03.031","volume":"79","author":"KA Orrell","year":"2018","unstructured":"Orrell KA, Cices AD, Guido N et al (2018) Malignant melanoma associated with chronic once-daily aspirin exposure in males: a large, single-center, urban, US patient population cohort study from the research on adverse drug events and report (RADAR) project. J Am Acad Dermatol 79(4):762\u2013764. https:\/\/doi.org\/10.1016\/j.jaad.2018.03.031","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"3056_CR21","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s10552-013-0227-8","volume":"24","author":"S Li","year":"2013","unstructured":"Li S, Liu Y, Zeng Z et al (2013) Association between non-steroidal anti-inflammatory drug use and melanoma risk: a meta-analysis of 13 studies. Cancer Causes Control CCC 24(8):1505\u20131516. https:\/\/doi.org\/10.1007\/s10552-013-0227-8","journal-title":"Cancer Causes Control CCC"},{"issue":"1","key":"3056_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/CEJ.0b013e328360f479","volume":"23","author":"H Hu","year":"2014","unstructured":"Hu H, Xie Y, Yang G, Jian C, Deng Y (2014) Nonsteroidal anti-inflammatory drug use and the risk of melanoma: a meta-analysis. Eur J Cancer Prev off J Eur Cancer Prev Organ ECP 23(1):62\u201368. https:\/\/doi.org\/10.1097\/CEJ.0b013e328360f479","journal-title":"Eur J Cancer Prev off J Eur Cancer Prev Organ ECP"},{"key":"3056_CR23","doi-asserted-by":"publisher","first-page":"104499","DOI":"10.1016\/j.phrs.2019.104499","volume":"152","author":"Y Ma","year":"2020","unstructured":"Ma Y, Yu P, Lin S, Li Q, Fang Z, Huang Z (2020) The association between nonsteroidal anti-inflammatory drugs and skin cancer: different responses in American and European populations. Pharmacol Res 152:104499. https:\/\/doi.org\/10.1016\/j.phrs.2019.104499","journal-title":"Pharmacol Res"},{"issue":"11","key":"3056_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1158\/1940-6207.CAPR-22-0229","volume":"15","author":"JZ Mai","year":"2022","unstructured":"Mai JZ, Kitahara CM, Sargen MR et al (2022) Use of nonsteroidal anti-inflammatory drugs and Incidence of Melanoma in the United States Radiologic technologists Study. Cancer Prev Res Phila Pa 15(11):727\u2013732. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-22-0229","journal-title":"Cancer Prev Res Phila Pa"},{"issue":"1","key":"3056_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.294.1.47","volume":"294","author":"NR Cook","year":"2005","unstructured":"Cook NR, Lee IM, Gaziano JM et al (2005) Low-dose aspirin in the primary prevention of cancer: the women\u2019s Health Study: a randomized controlled trial. JAMA 294(1):47\u201355. https:\/\/doi.org\/10.1001\/jama.294.1.47","journal-title":"JAMA"},{"key":"3056_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2147\/CCID.S311694","volume":"14","author":"J Brady","year":"2021","unstructured":"Brady J, Kashlan R, Ruterbusch J, Farshchian M, Moossavi M (2021) Racial disparities in patients with Melanoma: a Multivariate Survival Analysis. Clin Cosmet Investig Dermatol 14:547\u2013550. https:\/\/doi.org\/10.2147\/CCID.S311694","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"9","key":"3056_CR27","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1093\/jn\/137.9.2098","volume":"137","author":"S Hercberg","year":"2007","unstructured":"Hercberg S, Ezzedine K, Guinot C et al (2007) Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr 137(9):2098\u20132105. https:\/\/doi.org\/10.1093\/jn\/137.9.2098","journal-title":"J Nutr"},{"issue":"6","key":"3056_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1158\/1940-6207.CAPR-21-0244","volume":"15","author":"MK Yan","year":"2022","unstructured":"Yan MK, Orchard SG, Adler NR et al (2022) Effect of aspirin on Melanoma incidence in older persons: Extended follow-up of a large Randomized double-blind placebo-controlled trial. Cancer Prev Res Phila Pa 15(6):365\u2013375. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-21-0244","journal-title":"Cancer Prev Res Phila Pa"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03056-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03056-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03056-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T20:30:27Z","timestamp":1725913827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03056-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,8]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["3056"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03056-3","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,8]]},"assertion":[{"value":"10 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This literature review did not involve the use of patient data and thus, no ethics approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"367"}}